Background: Blindness caused by ophthalmic artery embolism is the most catastrophic complication of facial hyaluronic acid (HA) injections. Extravascular (retrobulbar) injection of hyaluronidase has been suggested as a salvage in this calamitous situation. However, the effectiveness of this treatment still lacks consensus.
Objectives: The aim of this study was to investigate the role of extravascular hyaluronidase in dissolving intravascular HA occlusion.
Methods: Two different animal experiments were performed: (1) isolated rabbit abdominal aorta segments filled with HA were treated with extravascular immersion of highly concentrated hyaluronidase for 90 minutes, followed by gross observation, microscopic examination, particle size analysis, and immunohistochemical staining; and (2) live rabbit auricular arteries were first occluded with HA and then immediately treated with extravascular injection of hyaluronidase. The ears were then evaluated by gross observation, microscopic examination, and perfusion studies after 60 minutes and again after 90 minutes.
Results: The HA within the aorta segments showed no gross or microscopic changes after treatment with extravascular hyaluronidase. Hyaluronidase could only be detected in adventitia of the aortae, instead of in vascular smooth muscle, tunica intima, or vascular lumen. The occluded auricular arteries showed no reperfusion after extravascular injection of hyaluronidase.
Conclusions: In this rabbit model, extravascular hyaluronidase was unable to penetrate into the arterial lumen of the isolated abdominal aorta or the live auricular artery of the rabbit to dissolve intravascular HA within a 90-minute time limit, thus casting doubt on whether extravascular (retrobulbar) hyaluronidase injection has a role in treating ophthalmic artery embolism caused by HA injections.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/asj/sjz280 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Successful Treatment of Hyaluronic Acid-Induced Facial Necrosis With Intravenous Dinoprostone.
Cureus
September 2024
Department of Dermatology, Cliniques universitaires Saint-Luc (UCLouvain), Brussels, BEL.
Article Synopsis
- - The rising popularity of facial dermal fillers, particularly hyaluronic acid, signals growing interest in cosmetic enhancements but comes with risks of complications.
- - A case study is presented involving a woman in her thirties who experienced severe facial skin necrosis after an accidental injection, which did not improve with local treatments.
- - After seven days of intravenous treatment with dinoprostone, a prostaglandin E2, the patient's condition showed significant improvement, highlighting a potential effective therapy for such complications.
Adverse Effects Associated with Dermal Filler Treatments: Part II Vascular Complication.
Diagnostics (Basel)
July 2024
Division in Anatomy and Developmental Biology, Department of Oral Biology, Human Identification Research Institute, BK21 FOUR Project, Yonsei University College of Dentistry, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Republic of Korea.
Vascular complications arising from dermal filler treatments pose significant risks, including ischemia, tissue necrosis, and severe outcomes like blindness and pulmonary embolism. This study investigates the mechanisms of vascular complications, categorizing them into extravascular compression and intravascular emboli. Extravascular compression occurs when injected fillers compress adjacent blood vessels, leading to ischemia and potential necrosis, while intravascular emboli result from fillers entering blood vessels, causing blockages.
View Article and Find Full Text PDFDescribing Intravenous Extravasation Injuries in Children (DIVE2 Study).
Can J Hosp Pharm
June 2024
, BSc, BSc(Pharm), ACPR, PharmD, FCSHP, BCPS, is with the Department of Pharmacy, Children's & Women's Health Centre of British Columbia, Lower Mainland Pharmacy Services, and the Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia.
Background: Extravasation is the erroneous delivery of IV medication or fluid into the extravascular space. Complications ranging from mild injury to amputation can result, depending on the physical and pharmacologic properties of the infusate. Children are at increased risk for extravasation injuries.
View Article and Find Full Text PDFModel-Based Dose Selection of Subcutaneous Nivolumab in Patients with Advanced Solid Tumors.
Clin Pharmacol Ther
March 2024
Bristol Myers Squibb, Princeton, New Jersey, USA.
The pharmacokinetics (PK) of intravenous (i.v.) nivolumab is well characterized.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!